Literature DB >> 34949589

Spectrum of Neuroradiologic Findings Associated with Monogenic Interferonopathies.

P Benjamin1, S Sudhakar2, F D'Arco2, U Löbel2, O Carney2, C-J Roux3, N Boddaert3,4, C Hemingway5, D Eleftheriou6, K Mankad2.   

Abstract

The genetic interferonopathies are a heterogeneous group of disorders thought to be caused by the dysregulated expression of interferons and are now commonly considered in the differential diagnosis of children presenting with recurrent or persistent inflammatory phenotypes. With emerging therapeutic options, recognition of these disorders is increasingly important, and neuroimaging plays a vital role. In this article, we discuss the wide spectrum of neuroradiologic features associated with monogenic interferonopathies by reviewing the literature and illustrate these with cases from our institutions. These cases include intracerebral calcifications, white matter T2 hyperintensities, deep WM cysts, cerebral atrophy, large cerebral artery disease, bilateral striatal necrosis, and masslike lesions. A better understanding of the breadth of the neuroimaging phenotypes in conjunction with clinical and laboratory findings will enable earlier diagnosis and direct therapeutic strategies.
© 2022 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2021        PMID: 34949589      PMCID: PMC8757560          DOI: 10.3174/ajnr.A7362

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  48 in total

1.  Neuroimaging in Aicardi-Goutières syndrome: Biomarkers for a progressive encephalopathy.

Authors:  Besim Uzgil; Elliott H Sherr
Journal:  Neurology       Date:  2015-11-18       Impact factor: 9.910

2.  COL4A1 mutations associated with a characteristic pattern of intracranial calcification.

Authors:  J Livingston; D Doherty; S Orcesi; D Tonduti; A Piechiecchio; R La Piana; E Tournier-Lasserve; A Majumdar; S Tomkins; G Rice; R Kneen; M van der Knaap; Y Crow
Journal:  Neuropediatrics       Date:  2011-12-01       Impact factor: 1.947

Review 3.  Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.

Authors:  John H Livingston; Yanick J Crow
Journal:  Neuropediatrics       Date:  2016-09-19       Impact factor: 1.947

4.  Neuropathological Findings in a Case of IFIH1-Related Aicardi-Goutières Syndrome.

Authors:  Ahmed Gilani; Laura A Adang; Adeline Vanderver; Abigail Collins; B K Kleinschmidt-DeMasters
Journal:  Pediatr Dev Pathol       Date:  2019-04-05

5.  Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C.

Authors:  Li Ma; Yun Zhou; Ying Zhang; Yuan Li; Yonghong Guo; Yu He; Jiuping Wang; Jianqi Lian; Chunqiu Hao; Jonathan P Moorman; Zhi Q Yao; Yongxing Zhou; Zhansheng Jia
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

6.  A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis.

Authors:  J Aicardi; F Goutières
Journal:  Ann Neurol       Date:  1984-01       Impact factor: 10.422

7.  Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

Authors:  Gillian I Rice; Candice Meyzer; Naïm Bouazza; Marie Hully; Nathalie Boddaert; Michaela Semeraro; Leo A H Zeef; Flore Rozenberg; Vincent Bondet; Darragh Duffy; Alba Llibre; Jinmi Baek; Mame N Sambe; Elodie Henry; Valerie Jolaine; Christine Barnerias; Magalie Barth; Alexandre Belot; Claude Cances; François-Guillaume Debray; Diane Doummar; Marie-Louise Frémond; Naoki Kitabayashi; Alice Lepelley; Virginie Levrat; Isabelle Melki; Pierre Meyer; Marie-Christine Nougues; Florence Renaldo; Mathieu P Rodero; Diana Rodriguez; Agathe Roubertie; Luis Seabra; Carolina Uggenti; Hendy Abdoul; Jean-Marc Treluyer; Isabelle Desguerre; Stéphane Blanche; Yanick J Crow
Journal:  N Engl J Med       Date:  2018-12-06       Impact factor: 91.245

8.  Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.

Authors:  Hanna Kim; Fatima Gunter-Rahman; John A McGrath; Esther Lee; Adriana A de Jesus; Ira N Targoff; Yan Huang; Terrance P O'Hanlon; Wanxia L Tsai; Massimo Gadina; Frederick W Miller; Raphaela Goldbach-Mansky; Lisa G Rider
Journal:  Arthritis Res Ther       Date:  2020-04-06       Impact factor: 5.156

9.  Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.

Authors:  Marco Prinz; Klaus-Peter Knobeloch
Journal:  Front Immunol       Date:  2012-04-09       Impact factor: 7.561

10.  Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2.

Authors:  Christopher J A Duncan; Benjamin J Thompson; Rui Chen; Gillian I Rice; Florian Gothe; Dan F Young; Simon C Lovell; Victoria G Shuttleworth; Vicky Brocklebank; Bronte Corner; Andrew J Skelton; Vincent Bondet; Jonathan Coxhead; Darragh Duffy; Cecile Fourrage; John H Livingston; Julija Pavaine; Edmund Cheesman; Stephania Bitetti; Angela Grainger; Meghan Acres; Barbara A Innes; Aneta Mikulasova; Ruyue Sun; Rafiqul Hussain; Ronnie Wright; Robert Wynn; Mohammed Zarhrate; Leo A H Zeef; Katrina Wood; Stephen M Hughes; Claire L Harris; Karin R Engelhardt; Yanick J Crow; Richard E Randall; David Kavanagh; Sophie Hambleton; Tracy A Briggs
Journal:  Sci Immunol       Date:  2019-12-13
View more
  1 in total

1.  Genotype-Phenotype Correlation and Functional Insights for Two Monoallelic TREX1 Missense Variants Affecting the Catalytic Core.

Authors:  Giulia Amico; Wayne O Hemphill; Mariasavina Severino; Claudio Moratti; Rosario Pascarella; Marta Bertamino; Flavia Napoli; Stefano Volpi; Francesca Rosamilia; Sara Signa; Fred Perrino; Marialuisa Zedde; Isabella Ceccherini
Journal:  Genes (Basel)       Date:  2022-06-30       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.